Alina Feinstein

Tzamal has been at the forefront of medical technology representing some of the most distinguished medical device companies in the world, for more than 35 years. During its first 25 years, the company represented established companies and focused on direct sales. Companies which chose Tzamal to represent them include Johnson & Johnson, Ohmeda (B&D) and Schneider (Pfizer). Medical Innovation Specialists Just over a decade ago Tzamal embarked on a bold and new path and therefore underwent a major reorganization. The company decided to devote almost a third of its resources to representing up and coming med-techs offering unique, innovative solutions. An intensive marketing program was introduced, specifically designed to familiarize the medical community with medical innovations. Thanks to this strategy, Tzamal is today recognized for its expertise in promoting and achieving sales for young medical technology innovators. The company is proud of its unique ability to break-down barriers and guide hospital administrators throughout replacement of obsolete medical technologies with innovative ones. Comprehensive Solution Tzamal is active in most major med-tech markets via its six subsidiaries: Tzamal Jakobsohn – Innovative devices and technology for surgery, orthopedics, cardiology, neurosurgery and spinal applications. Tzamal Bio-Pharma – Specialty biotechnologies and pharmaceuticals, orphan drugs for rare diseases Tzamal M.P.VET – Veterinary products, technologies and equipment Tzamal 2B Capital Medical Equipment – High-tech capital equipment for all areas of healthcare industry Tzamal Medicare – Innovative technology for primary and home care Tzamal D-Chem Laboratories – Chemicals for research